BloebaumR.Managing allergic rhinitis: the role of pharmacotherapy; sound treatment can improve your patient’s quality of life. J Respir Dis. 2002;
23:370–376.
2.
NathanRA.The burden of allergic rhinitis.Allergy Asthma Proc. 2007;
28:3–9.
3.
SettipaneRA.Rhinitis: a dose of epidemiological reality.Allergy Asthma Proc. 2003;
24:147–154.
4.
Golding-WoodPH.Observations on petrosal and vidian neurectomy in chronic vasomotor rhinitis.J Laryngol Otol. 1961;
75(3):232–247.
5.
FernandesCM.Bilateral transnasal vidian neurectomy in the management of chronic rhinitis.J Laryngol Otol. 1994;
108(7):569–573.
6.
KompelliARJanzTARowanNRNguyenSASolerZM.Cryotherapy for the treatment of chronic rhinitis: a qualitative systematic review. Am J Rhinol Allergy. 2018;
32(6):491–501.
7.
ZhouAHChungSYSylvesterMJet al.To pack or not to pack: inpatient management of epistaxis in the elderly. Am J Rhinol Allergy. 2018;
32(6):539–545.
8.
ChenPGBassiouniATaylorCB.Teaching residents frontal sinus anatomy using a novel 3-dimensional conceptualization planning software-based module. Am J Rhinol Allergy. 2018;
32(6):526–532.
9.
PapagiannopoulosPKuharHNRamanA.Understanding the propensity for chronic sinusitis in patients on immunosuppressive therapy. Am J Rhinol Allergy. 2018;
32(6):478–484.
10.
OliverJDLimKGO’BrienEK.Correlation of exhaled nasal nitric oxide with sinus computed tomography and sinonasal outcome test scores: a cross-sectional pilot study. Am J Rhinol Allergy. 2018;
32(6):533–538.
11.
WuDWassermanJBorukM.Practice patterns of systemic corticosteroid use in complicated acute rhinosinusitis among rhinologists and pediatric otolaryngologist. Am J Rhinol Allergy. 2018;
32(6):485–490.
12.
ZhouBHuangQSunJ.Resection of inverted papilloma of the maxillary sinus via a prelacrimal recess approach: a multicenter retrospective analysis of surgical efficacy.Am J Rhinol Allergy. 2018;
32(6):518–525.
13.
BadranKWSuhJDNamiriNWrobelBFerenceEH.Pediatric benign paranasal sinus osteoneogenic tumors: a case series and systematic review of outcomes, techniques, and a multiportal approach. Am J Rhinol Allergy. 2018;
32(6):465–472.
14.
LiuYXingZWangJGengC.Salivary immunoglobulin A, E, and G4 levels specific to Dermatophagoides pteronyssinus in allergic rhinitis patients treated with subcutaneous immunotherapy. Am J Rhinol Allergy. 2018;
32(6):458–464.
15.
MulukNBAltınFCingiF.Role of superantigens in allergic inflammation: their relationship to allergic rhinitis, chronic rhinosinusitis, asthma, and atopic dermatitis. Am J Rhinol Allergy. 2018;
32(6):502–517.
16.
KeefeKRNgo-HowardMPlattMPBrookCD.Compliance with subcutaneous immunotherapy appointments in an urban tertiary care setting. Am J Rhinol Allergy. 2018;
32(6):473–477.
